4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-030953
Options or other derivatives
- Director acquired 23,900 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Greene Barry E Director | 2022-05-19 | Grant or award · Nonstatutory Stock Option (right to buy) | +23,900 | 23,900 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…